Insights into the Assessment of Measurable Residual Disease (MRD) in Patients With Multiple Myeloma

被引：0
|
作者：
Costa, Luciano J. [1 ,2 ,3 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Sch Med, ONeal Comprehens Canc Ctr Clin Trials Off, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Sch Med, Hematol Malignancies Working Grp, Hematol & Oncol, Birmingham, AL 35294 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：11 / 16
页数：6
相关论文
共 50 条
  • [1] Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma: A Review of the Data
    Bal, Susan
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 3 - 10
  • [2] Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma: A Review of the Data
    Wolf, Jeffrey
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (03)
  • [3] Minimally Invasive Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma (MM)
    Gonzales, Carmen
    Lasa, Marta
    Notarfranchi, Laura
    Agullo, Cristina
    Cuenda, Natalia Buenache
    Zherniakova, Anastasiia
    Castro, Sergio
    Perez, Jose Juan
    Gonzalez-Calle, Veronica
    Romero, Maria Teresa Cedena
    Barrio, Santiago
    Martin-Munoz, Alejandro
    Burgos, Leire
    Alignani, Diego
    Calasanz, Maria Jose
    Otero, Paula Rodriguez
    Rosinol, Laura
    De Arriba, Felipe
    Ocio, Enrique M.
    Rocafiguera, Albert Oriol
    Palomera, Luis
    Gonzalez-Montes, Yolanda
    Balari, Anna Maria Sureda
    Garcia, Miguel Teodoro Hernandez
    Sanchez, Maria Esther Clavero
    Garcia, Angela Ibanez
    Gomez, Clara
    Orfao, Alberto
    Mateos, Maria Victoria
    Palacios, Juan Jose Lahuerta
    Blade, Joan
    San-Miguel, Jesus
    Martinez-Lopez, Joaquin
    Puig, Noemi
    Paiva, Bruno
    BLOOD, 2023, 142
  • [4] Best Practices for the Assessment of Measurable Residual Disease (MRD) in Multiple Myeloma: Further Observations
    Costa, Luciano J.
    Bal, Susan
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 17 - 17
  • [5] Voyage of Measurable Residual Disease (MRD) Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry
    Das, Nupur
    Gupta, Ritu
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023, 44 (05) : 515 - 524
  • [6] Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
    Maiolino, Angelo
    Da Costa, Elaine Sobral
    Orfao, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Measurable residual disease (MRD) and clonal diversity for multiple myeloma treatment monitoring.
    Martinez-Lopez, Joaquin
    Wong, Sandy Wai Kuan
    Lopez-Munoz, Nieves
    Bahri, Natasha
    Arora, Shagun
    Kuan, Mikaela
    Dorado, Sara
    Barrio, Santiago
    Chung, Alfred
    Martin, Thomas G.
    Wolf, Jeffrey Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Challenges and opportunities in the assessment of measurable residual disease in multiple myeloma
    Bal, Susan
    Weaver, Allison
    Cornell, Robert F.
    Costa, Luciano J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (06) : 807 - 819
  • [9] Ultra-Sensitive Assessment of Measurable Residual Disease (MRD) in Peripheral Blood (PB) of Multiple Myeloma (MM) Patients Using Bloodflow
    Notarfranchi, Laura
    Zherniakova, Anastasiia
    Lasa, Marta
    Puig, Noemi
    Teresa Cedena, Maria
    Martinez-Lopez, Joaquin
    Jose Calasanz, Maria
    Alignani, Diego
    Burgos, Leire
    Manrique, Irene
    Huang, Yi-Ju
    Fracowiak, Jochen
    Gomez, Clara
    De Arriba, Felipe
    Rodriguez-Otero, Paula
    Palomera, Luis
    Sureda, Anna
    Clavero Sanchez, Maria Esther
    Angel Alvarez, Miguel
    Ibanez Garcia, Angela
    Hernandez, Miguel-Teodoro
    Perez, Albert
    Pilar Gonzalez, Ana
    Ocio, Enrique M.
    Flores-Montero, Juan
    Orfao, Alberto
    Jose Lahuerta, Juan
    Mateos, Maria-Victoria
    Rosinol, Laura
    Blade Creixenti, Joan
    San-Miguel, Jesus
    Paiva, Bruno
    BLOOD, 2022, 140 : 2095 - 2097
  • [10] Predictors of unsustained measurable residual disease (MRD) negativity in transplant-eligible multiple myeloma (MM) patients
    Guerrero, Camila
    Puig, Noemi
    Cedena, Teresa
    Calasanz, Maria-Jose
    Gutierrez, Norma
    Fernandez-Guijarro, Manuela
    Oriol, Albert
    Rios, Rafael
    Hernandez Garcia, Miguel Teodoro
    Martinez-Martinez, Rafael
    Bargay, Joan
    de Arriba de la Fuente, Felipe
    Palomera, Luis
    Pilar Gonzalez-Rodriguez, Ana
    Gonzalez-Perez, Marta-Sonia
    Orfao, Alberto
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Rosinol, Laura
    Blade, Joan
    Lahuerta Palacios, Juan Jose
    San-Miguel, Jesus
    Paiva, Bruno
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S7 - S8
12345